Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

Published:2014-11-11 Issue:6 Volume:121 Page:863-871
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Shimoni Avichai¹,Volchek Yulia¹,Koren-Michowitz Maya¹,Varda-Bloom Nira¹,Somech Raz¹,Shem-Tov Noga¹,Yerushalmi Ronit¹,Nagler Arnon¹

Affiliation:

1. Division of Hematology and Bone Marrow Transplantation; Chaim Sheba Medical Center; Tel-Hashomer Israel

Funder

Novartis

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

2. Optimal approach to treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: how to best use all the available tools;Ribera;Leuk Lymphoma,2013

3. Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias;Shimoni;Leukemia,2003

4. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia;Lee;Blood,2008

5. The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia;Oehler;Blood,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia;BMC Medical Genomics;2024-05-29

2. Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicenter retrospective study;Cancer;2024-02-05

3. Tyrosine Kinase Inhibitor-associated Cerebral Arterial Occlusive Disease Treated with High-flow Bypass Surgery: A Case Report;NMC Case Report Journal;2023-12-31

4. Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia;Frontiers in Immunology;2023-06-08

5. Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia;International Journal of Hematology;2023-02-20